awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36720304-A9D975EE-6BB4-44B6-AF24-4A1D5729193C
Q36720304-A9D975EE-6BB4-44B6-AF24-4A1D5729193C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36720304-A9D975EE-6BB4-44B6-AF24-4A1D5729193C
The efficacy and safety of insulin degludec given in variable once-daily dosing intervals compared with insulin glargine and insulin degludec dosed at the same time daily: a 26-week, randomized, open-label, parallel-group, treat-to-target trial in i
P2860
Q36720304-A9D975EE-6BB4-44B6-AF24-4A1D5729193C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36720304-A9D975EE-6BB4-44B6-AF24-4A1D5729193C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
afa1f19533cb2c5760993278b2b74f6bb3150617
P2860
Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 2 diabetes (BEGIN Basal-Bolus Type 2): a phase 3, randomised, open-label, treat-to-target non-inferiority tria